• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

Why Globalization Works

Diary, Newsletter

Having been a vociferous supporter of globalization since its dawn, first during a decade spent as a reporter for The Economist magazine, and then as an investor, I can explain how our international trading system works, and especially why it works for the US.

While waiting for a flight at Miami Airport, there was a polyglot of travelers from all over the world.

Large groups of Chinese were led by flag-bearing guides. Italian Millennials mobbed the bars at night. English couples strolled the majestic limestone fortress walls soaking up the sunshine. 

There was even the occasional American student backpacker repeating my own adventure from the 1960’s.

And you know what? This disparate international group shared many things in common.

Most of them spent much of the day glued to iPhones or Androids run by US-designed apps. Many were staying in accommodations organized by Airbnb (there were over 200 listings for the immediate Dubrovnik area).

They may have made the trip from the airport in an Uber cab. They wore Levis Strauss blue jeans. American pop music pulsed through their earbuds. Probably half of them arrived on a Boeing jet financed by the US Export-Import Bank.

In short, they were all sending enormous amounts of money to US companies and shareholders in more ways than they could possibly count, without realizing it.

You never used to see tourists from most countries, like Russia, Spain, Portugal, Italy, or Ireland.

They were too poor.

Rapidly rising standards of living created by globalization changed all of that, creating an enormous new market for American products, especially technology ones.

My Airbnb neighbors in Dubrovnik included a family from Malaysia and a young couple from South Korea.

You can see some of this impact in international balance of trade statistics. In 2024, the US ran a trade deficit with the world of $634 billion with consumer electronics, oil, clothes, and cars our largest imports.

Subtract our $294 billion surplus in services, which includes, financial services, education, patents, and other intellectual property, and that brings our current account deficit down by more than half to only $340 billion.

But that doesn’t tell the whole story.

Trade data completely misses the enormous number of products and services that are now given away FOR FREE in exchange for the chance of earning some uncertain revenue at some future date.

And I include none other than the esteemed Mad Hedge Fund Trader in this category. Something like 99% of the visitors to my site never pay anything.

The monetary market value of the research I have given away for free is probably worth tens of millions of dollars.

In a pre-Internet, pre-globalized world, a service covering so many asset cases and individual stocks in real-time might have cost $100,000, if not $1 million.

And you know what? It would have been worth it!

Multiply this effect on a global scale and you see what I am talking about.

Give up your name and email address, and you can obtain almost any kind of online service for nothing. And as far as I know, no government agency has any measurement of this whatsoever.

Needless to say, the United States is far and away the leader in this immeasurable field.

By the way, this might also be the reason why the published productivity data has been so poor, despite the fact that US GDP has grown by 20% since 2009. Everywhere I look productivity is skyrocketing, including my own.

It also might be the reason why Amazon continuously sports a nosebleed valuation. Much of what they provide is FREE, and therefore immeasurable.

Of course, globalization wrought havoc on your life if you went into it with the wrong job in the wrong industry and an inadequate skill set.

Blue-collar workers tied to textiles, shoes, toys, and other low-value-added manufacturing were toast, as their jobs fled offshore.

If you didn’t retrain, or adapt you became an angry, mostly white man.

As my friend, New York Times columnist Tom Friedman likes to say, “Average doesn’t cut it anymore.”

However, while the jobs are gone, the bulk of the profits stayed here in the US. American companies offshored the $ 2-an-hour jobs (mass assembly) but kept the $100 an hour ones (design and marketing).

As my friends in the Chinese government never fail to point out, if they build the iPhone for $100 and we sell it for $1,500, we are the big winners, not them.

They believe we are perpetuating 19th-century colonialism by making wage slaves of their workers.

They may be right.

Globalization enables the US dollar to continue as the world’s reserve currency, as almost all international trade is conducted in the buck.

That is one of the greatest free lunches of all time. It enables the US government to indirectly control the global economy through its own monetary policy. Some half of all US government debt is owned by foreigners.

When sanctions forced Iran to drop out of the international trading system what did they get? A Great Depression that cut their GDP by 25%. You can’t run a country of 80 million with oil barter deals, gold, and bitcoins alone.

There are also the huge defense benefits that globalization brings us.

Back in the early days, the main reason to steer a country into capitalism was to prevent it from going communist, and therefore becoming an enemy.

Grow your allies and shrink your enemies, and your defense costs shrink dramatically, raising our standard of living.

That is what has happened.

Increased trade also boosted foreign standards of living, therefore creating a growing market for American goods and services.

This was the whole point of the World Trade Organization, NAFTA, and the Trans-Pacific Partnership.

Humans rarely bite the hands that feed them. They are also highly unlikely to set fire to their paycheck or bomb the sources of income.

Make a foreigner a millionaire, and you turn him into a pacifist. I have seen this unfold time and again over the past half-century, be it in China, Russia, Vietnam, Cambodia, and most recently in Iran.

Create an embedded base of businessmen in any country who are getting rich off of you, and international relations invariably improve.

Any system based on greed is guaranteed to succeed.

A side benefit of all of this is that stock markets for up forever.

Since globalization started in earnest in 1951, the Dow Average has risen from $239 to $18,392, a prodigious gain of some 77-fold.

And you wondered why?

Globalization is the mechanism through which America is paid the dividend for all of the good deeds it has done and inventions it has created for the past century.

I am thinking about the construction of the Panama Canal, Lend Lease, and the Marshall Plan, as well as the transistor, memory chip, microprocessor, personal computer, Windows, the Internet, online commerce, the iPhone, and social media.

That is why globalization is a win-win-win for everyone.

There are really only two true communist countries left in the world, Cuba and North Korea, which never joined the international trading community. They also happen to have the planet’s lowest standard of living.

And Cuba will become totally capitalist within two years. Just give them a million iPhones, get them talking, and see what happens. Castro will become just another neighborhood in South San Francisco.

So why end a trading system from which America and its people have profited so mightily?

Exploring the Wonders of International Trade

https://www.madhedgefundtrader.com/wp-content/uploads/2025/01/john-thomas-with-woman.png 612 606 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-01-29 09:02:562025-02-20 12:40:32Why Globalization Works
Mad Hedge Fund Trader

January 29, 2025 - Quote of the Day

Diary, Newsletter, Quote of the Day

“We have few, if any spare tires left,” said Mohamed El-Erian, CIO of mega bond house PIMCO, about the nail studded road ahead for the US economy.

https://www.madhedgefundtrader.com/wp-content/uploads/2013/07/Nails.jpg 218 324 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2025-01-29 09:00:052025-01-29 10:44:44January 29, 2025 - Quote of the Day
april@madhedgefundtrader.com

Trade Alert - (ADBE) January 28, 2024 - BUY

Tech Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-01-28 13:29:252025-01-28 13:29:25Trade Alert - (ADBE) January 28, 2024 - BUY
april@madhedgefundtrader.com

Trade Alert - (VST) January 28, 2024 - BUY

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-01-28 13:06:232025-01-28 13:06:23Trade Alert - (VST) January 28, 2024 - BUY
april@madhedgefundtrader.com

January 28, 2025

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
January 28, 2025
Fiat Lux

 

Featured Trade:

(READY, RESET, GO)

(JNJ), (AAPL), (PFE), (ABBV), (RHHBY), (AZN),  (SNY), (NVS)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-01-28 12:02:492025-01-28 13:14:05January 28, 2025
april@madhedgefundtrader.com

Ready, Reset, Go

Biotech Letter

I had to laugh when I saw Johnson & Johnson's (JNJ) Q4 earnings hit my screen earlier this month.

Here we have Wall Street wringing its hands over a slight revenue miss, sending shares down 3.5%, while management is busy plotting its path to pharma industry dominance.

The numbers tell an interesting story.

Q4 revenues grew 5.3% (or 5.7% on an adjusted operational basis) to $22.5 billion. Wall Street got the vapors because earnings came in at $1.41 per share, well below their $2.04 consensus.

Reminds me of the time analysts completely missed Apple's (AAPL) transformation into a services company.

For the full year 2024, JNJ delivered 4.3% sales growth (5.4% operational) to $88.8 billion, with earnings per share landing at $5.79, or $9.98 adjusted after swallowing a $(0.67) hit from acquired IPR&D charges.

Not too shabby for a company in transition.

Looking into 2025, management is guiding for 2.5-3.5% operational sales growth ($90.9-91.7 billion) and adjusted operational EPS of $10.75-$10.95.

That's 8.7% growth at the midpoint, though they're careful to hedge around legal proceedings and acquisition costs.

And here's where it gets interesting.

During last week's JP Morgan Healthcare Conference, CEO Joaquin Duato was practically bouncing in his chair about their drug pipeline. Let's look at what's got him so excited.

Darzalex, their multiple myeloma superstar, raked in $11.67 billion in 2024, up 20%.

The new kid Carvykti exploded 93% higher to $963 million. Tecvayli landed $550 million in its rookie year.

Depression med Spravato jumped 56% to hit the magic $1 billion mark. Tremfya, their Stelara successor, grew 17% to $3.7 billion.

Speaking of Stelara – there's the elephant in the room.

JNJ's crown jewel is losing patent protection, already showing up in Europe with a >12% sequential decline in Q4 to $2.35 billion. Expect a 30% "haircut" this year.

But here's what Wall Street is missing: JNJ saw this coming years ago.

They just dropped $14.6 billion on Intracellular Therapies, mostly debt-funded (they can afford it with only $31.3 billion in long-term debt and $19.98 billion in cash).

This brings them Caplyta, an antipsychotic med with blockbuster potential that's already approved for schizophrenia and bipolar disorders.

The medical device business isn't sitting still either.

Q4 worldwide revenues jumped 6.7% year-on-year. While Surgery was flat at $2.5 billion and Orthopedics grew a modest 2.5% to $2.32 billion, Vision popped 9% to $1.3 billion.

But the real story? Cardiovascular surged 24% to $2.1 billion. Those Shockwave and Abiomed acquisitions are looking pretty smart right about now.

For the year, MedTech grew 4% to $31.56 billion. Operating margins slipped a bit – Innovative Medicines down from 42% to 39.4%, MedTech from 23.7% to 21.6%.

Late-stage pipeline products nearing approval should ease R&D expenses in 2025, just as JNJ gears up for its next growth phase.

The foundation looks rock solid - $19.98 billion in cash, $31.3 billion in long-term debt, 2025 adjusted EPS guidance of $10.75-$10.95, and that reliable $1.24 quarterly dividend.

But forget the current numbers - the real money's in what's coming next.

Here's what the market is missing: JNJ is promising 5-7% compound annual growth between 2025-2030, with ten drugs hitting $5+ billion in annual sales by decade's end.

Sound ambitious? Maybe. But they've got the pipeline to back it up – from immunology stars nipocalimab and icotrokinra to neuroscience contenders seltorexant and aticaprant, plus oncology plays like TAR-200 for bladder cancer.

I've seen this movie before with AbbVie (ABBV), which navigated the loss of $20+ billion Humira without missing a beat.

And JNJ looks even better positioned - their pharma division is targeting $58 billion in 2024 revenues, which would make them the biggest player in Big Pharma, ahead of Pfizer (PFE), AbbVie (ABBV), Roche (RHHBY), AstraZeneca (AZN), Sanofi (SNY) and Novartis (NVS).

The only real wildcard? That pesky talc litigation.

JNJ's latest move – spinning the lawsuits into Red River Talc LLC and filing for bankruptcy – could cap the damage at $8.5 billion. They claim 75% of claimants are on board, with a court ruling expected this month.

So, what's my take? I think JNJ's 2025 will be a "reset" year, especially the first half. But just like buying straw hats in winter, there might be an opportunity here for patient investors. Management says the back half will be stronger, setting up 2026 for what could be a very interesting guidance call.

While the market frets about Stelara's patent cliff, smart money is quietly building positions. That's why I'm maintaining my stand to buy the dip.

After all, sometimes the best trades are the ones that make you a bit uncomfortable at first. And if you're worried about patent cliffs, just ask any AbbVie shareholder how that worked out for them.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-01-28 12:00:202025-01-28 12:23:27Ready, Reset, Go
april@madhedgefundtrader.com

Trade Alert - (NVDA) January 28, 2025 - BUY

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-01-28 10:24:052025-01-28 10:24:05Trade Alert - (NVDA) January 28, 2025 - BUY
april@madhedgefundtrader.com

January 28, 2025

Diary, Newsletter, Summary

Global Market Comments
January 28, 2025
Fiat Lux

 

Featured Trade:

(THE NEW OFFSHORE CENTER: AMERICA),
(SIGN UP NOW FOR TEXT MESSAGING OF TRADE ALERTS)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-01-28 09:06:572025-01-28 11:44:37January 28, 2025
april@madhedgefundtrader.com

January 27, 2025

Tech Letter

Mad Hedge Technology Letter
January 27, 2025
Fiat Lux

 

Featured Trade:

(DEEPSEEK PUTS A SCARE INTO TECH STOCKS)
(CHINA), (NVDA)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-01-27 14:04:082025-01-28 11:19:51January 27, 2025
april@madhedgefundtrader.com

DeepSeek Puts A Scare Into Tech Stocks

Tech Letter

The narrative that China is a decade behind in cutting-edge technology compared to Silicon Valley is total B.S. at this point.

It couldn’t be further from the truth.

First, it was the smartphone where Apple built an insurmountable lead for the Chinese.

Second, it was the EV and no Chinese company would ever surpass Tesla.

China is now leading in both EVs and smartphones at this point.

This narrative has been debunked and today is the final nail in the coffin.

Now…enter the wrath of artificial intelligence where reports indicate China has produced that aha moment in which China has managed to output the same quality of AI without Nvidia supercomputers and without a $100 million data centers.

Imagine the sigh of relief from American households that won’t have to deliver an electricity wealth transfer to Silicon Valley.

If this holds true, the Chinese have played the CEO of ChatGPT Sam Altman like a fiddle.

It’s extremely worrisome that Altman has irked Elon Musk so badly that it is widely known that Altman is Musk’s arch-enemy.

For everyone who doesn’t know, the app is called DeepSeek and it is now #1 in the Appstore.

Chinese artificial intelligence startup DeepSeek’s latest AI model sparked a multi-trillion rout in US and European technology stocks.

DeepSeek is a visible challenge to costlier models like OpenAI and raising suspicious if Sam Altman is just taking Silicon Valley on a ride for his gargantuan bank account.

Nvidia tanked 17% by mid-day and clearly would be one of the companies hurt by the Chinese.

DeepSeek shows that it is possible to develop powerful AI models that cost less and can potentially derail the investment case for the entire AI supply chain, which is driven by high spending from a small handful of hyperscalers.

The AI model from DeepSeek — founded by quant fund chief Liang Wenfeng — is widely seen as better than ChatGPT and will no doubt be a better value.

The DeepSeek product is deeply problematic for the thesis that the significant capital expenditure and operating expenses that Silicon Valley has incurred are the most appropriate way to approach the AI trend.

The DeepSeek release raises new doubts, challenging the notion that China’s AI technology is a decade behind US counterparts. Washington’s trade restrictions had kept the most cutting-edge chips out of China’s hands, but DeepSeek’s model was built using open-source technology that is easy to access.

The biggest and most important takeaway from this chaos is that Nvidia is now canceled as the best buy and holds long-term tech stock.

The newfound competition instills pricing issues for Nvidia and raises questions about the very model they support.

Many asset classes have become overly expensive and the narrow reason for the pricing to stay higher is the lack of competition.

So what now?

Although I don’t expect Nvidia’s stock to experience a straight move lower, this puts a hard ceiling on any meaningful stock appreciation for the rest of 2025.

This new development also puts hard ceilings on other AI chip stocks looking to benefit from those higher premiums.

Then the question of what is the next big thing to come from Silicon Valley is again thrust to the fore.

Innovation has been behind in California and Altman is looking less credible by the day.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-01-27 14:02:102025-01-27 16:03:03DeepSeek Puts A Scare Into Tech Stocks
Page 3 of 14‹12345›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top